BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30729804)

  • 1. Combining surveillance systems to investigate local trends in tuberculosis-HIV co-infection.
    Davy-Mendez T; Shiau R; Okada RC; Moss NJ; Huang S; Murgai N; Chitnis AS
    AIDS Care; 2019 Oct; 31(10):1311-1318. PubMed ID: 30729804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV prevalence in the Israeli tuberculosis cohort, 1999-2011.
    Zohar M; Moshe L; Daniel C; Noa C; Itamar G
    BMC Public Health; 2014 Oct; 14():1090. PubMed ID: 25335562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis and HIV co-infection in European Union and European Economic Area countries.
    Pimpin L; Drumright LN; Kruijshaar ME; Abubakar I; Rice B; Delpech V; Hollo V; Amato-Gauci A; Manissero D; Ködmön C
    Eur Respir J; 2011 Dec; 38(6):1382-92. PubMed ID: 21737549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis and HIV co-infection, California, USA, 1993–2008.
    Metcalfe JZ; Porco TC; Westenhouse J; Damesyn M; Facer M; Hill J; Xia Q; Watt JP; Hopewell PC; Flood J
    Emerg Infect Dis; 2013 Mar; 19(3):400-6. PubMed ID: 23745218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis rates among HIV-infected persons in New York City, 2001-2005.
    Trieu L; Li J; Hanna DB; Harris TG
    Am J Public Health; 2010 Jun; 100(6):1031-4. PubMed ID: 20395574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population-based study determining the incidence of tuberculosis attributable to HIV infection.
    Snyder DC; Mohle-Boetani JC; Chandler A; Oliver G; Livermore T; Royce S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):190-4. PubMed ID: 9390571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian modeling of spatiotemporal patterns of TB-HIV co-infection risk in Kenya.
    Otiende V; Achia T; Mwambi H
    BMC Infect Dis; 2019 Oct; 19(1):902. PubMed ID: 31660883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for tuberculosis and specific manifestations of disease.
    Zielonka TM
    Przegl Epidemiol; 2014; 68(4):637-43. PubMed ID: 25848783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in contributing factors to tuberculosis incidence in U.S. -born and foreign-born persons.
    Chin DP; DeRiemer K; Small PM; de Leon AP; Steinhart R; Schecter GF; Daley CL; Moss AR; Paz EA; Jasmer RM; Agasino CB; Hopewell PC
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1797-803. PubMed ID: 9847270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The burden of HIV on Tuberculosis patients in the Volta region of Ghana from 2012 to 2015: implication for Tuberculosis control.
    Osei E; Der J; Owusu R; Kofie P; Axame WK
    BMC Infect Dis; 2017 Jul; 17(1):504. PubMed ID: 28724359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult tuberculosis in Israel and migration: trends and challenges between 1999 and 2010.
    Mor Z; Pinsker G; Cedar N; Lidji M; Grotto I
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1613-8. PubMed ID: 23131258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of smear-negative pulmonary tuberculosis in the United States, 1993-2008.
    Shah NS; Cavanaugh JS; Pratt R; Cain KP; Wells C; Laserson K; Nelson L
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1234-40. PubMed ID: 22748057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of HIV and tuberculosis co-infection in Montreal, Quebec.
    Rivest P; Sinyavskaya L; Brassard P
    Can J Public Health; 2014 May; 105(4):e263-7. PubMed ID: 25166128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of human immunodeficiency virus among pulmonary tuberculosis patients: A cross-sectional study.
    Moglad EHO; Ahmed DAO; Awad Al-Kareem SMM; Elgoraish AG; Ali HTO; Altayb HN
    Microbiol Immunol; 2020 Dec; 64(12):810-814. PubMed ID: 33090528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with tuberculosis by HIV status in the Brazilian national surveillance system: a cross sectional study.
    do Prado TN; Miranda AE; de Souza FM; Dias Edos S; Sousa LK; Arakaki-Sanchez D; Sanchez MN; Golub JE; Maciel EL
    BMC Infect Dis; 2014 Jul; 14():415. PubMed ID: 25066655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TB treatment outcomes among TB-HIV co-infections in Karnataka, India: how do these compare with non-HIV tuberculosis outcomes in the province?
    Shastri S; Naik B; Shet A; Rewari B; De Costa A
    BMC Public Health; 2013 Sep; 13():838. PubMed ID: 24025316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proportion of tuberculosis cases in Tanzania attributable to human immunodeficiency virus.
    van Cleeff MR; Chum HJ
    Int J Epidemiol; 1995 Jun; 24(3):637-42. PubMed ID: 7672908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: a prospective observational study.
    Pontororing GJ; Kenangalem E; Lolong DB; Waramori G; Sandjaja ; Tjitra E; Price RN; Kelly PM; Anstey NM; Ralph AP
    BMC Infect Dis; 2010; 10():362. PubMed ID: 21605474
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.